Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Desloratadine as Add-On Therapy in Rheumatoid Arthritis
NCT07632872Phase 2Recruiting
- Sponsor
- Horus Pharma
- Start
- May 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
A Phase 2 trial of desloratadine in rheumatoid arthritis (RA), sponsored by Horus Pharma. Started May 2026; status: recruiting.
02
Drugs
desloratadine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07632872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07632872.